Dopamine receptor elevation by cholecystokinin

This publication has 18 references indexed in Scilit:

• Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro
  Published by Elsevier ,2003
• The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat
  Neuroscience Letters, 1984
• Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas
  Peptides, 1984
• Neurotensin effects on brain dopaminergic systems
  Brain Research, 1982
• Modulation by cholecystokinins of ³H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites
  Acta Physiologica Scandinavica, 1981
• Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice
  European Journal of Pharmacology, 1981
• A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing
  Neuroscience, 1980
• Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment
  Nature, 1980
• Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection
  European Journal of Pharmacology, 1980
• Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1978